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1 |  INTRODUCTION
Diagnostic evaluation of cardiac tumors and the decision 
on cardiac surgery remain a clinical challenge. No interna-
tional consensus document exists on diagnostic evaluation 
or treatment strategy in patients with cardiac masses. With 
an incidence of 0.001%-0.03%, primary cardiac tumors are 
rare even in a major cardiac surgery center.1,2 When a car-
diac mass is discovered, further clinical assessments, choice 
of imaging modalities, and treatment strategy are generally 
decided based upon local expert opinion.
Since its entry into the medical field, echocardiography 
has been the primary imaging technique in the assessment 
of cardiac tumors.3 Additional imaging modalities, includ-
ing cardiac magnetic resonance (CMR), might give crucial 
information in diagnostic evaluation of cardiac masses.
2 |  CASE PRESENTATION
A 67-year-old female without previous cardiac history was 
admitted with palpitations. Prehospital electrocardiogram 
showed regular supraventricular tachycardia at a ventricu-
lar rate of 213 bpm. On suspicion of reentry tachycardia, in-
travenous Adenosine was given at a dose of 6 mg and after 
few minutes, further 12  mg was given without achieving 
conversion to sinus rhythm. Based on the presence of flutter 
waves during the transient AV block, the diagnosis of atrial 
flutter was made. Conversion to sinus rhythm was obtained 
by intravenous administration of 300  mg Amiodarone. 
Transthoracic echocardiogram (TTE) showed a solid mass 
of 5 × 3 cm in the right atrium attached to the intra-atrial 
septum. Transesophageal echocardiogram (TOE) showed 
no affection of the tricuspid valve. No hemodynamic 
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Abstract
Cardiac magnetic resonance in cardiac mass: Cardiac magnetic resonance (CMR) 
should be considered in the evaluation of patients with cardiac mass. Especially, 
when the diagnosis is not certain, CMR could provide paramount information that 
could be helpful for the decision on cardiac surgery.
K E Y W O R D S
cardiac magnetic resonance, cardiac mass, cardiac tumor, cardiothoracic surgery, 
echocardiography, lipomatous atrial septal hypertrophy
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obstruction of the atrial cavity, inferior, or superior caval 
veins were present (Figure 1 panel A, and Video S1-S2). 
Left ventricular function, right ventricular function, and all 
heart valves were without pathological findings. The tumor 
was suspected to be a right-sided myxoma, and the patient 
was referred to cardiothoracic surgery. There was no evi-
dence of embolic phenomena. The SVT was concluded to 
be the first and single symptom of the tumor, knowing that 
the episode of SVT might not be necessarily related to the 
cardiac mass.
To rule out the presence of coronary stenosis prior to 
cardiothoracic surgery, cardiac computed tomography (CT) 
was performed, showing normal coronary arteries. Second 
review of the echocardiographic images at the heart team 
conference drew attention to the tumor's broad-based at-
tachment to the intra-atrial septum, reduced mobility and 
absence of a narrow stalk. CMR was requested. CMR with 
T1- and T2-weighted images including fat suppression and 
gadolinium-based contrast revealed that the solid mass 
consisted of widespread lipomatous atrial septum hyper-
trophy (LASH) due to fatty infiltration. The tumor had a 
classic dumbbell shape with sparing of the fossa ovalis (The 
findings on echocardiography, CT, and CMR are showed 
on Figure 1, panel A-F, and Video S1-S3). The scheduled 
surgery was cancelled. Due to intermittent episodes of atrial 
fibrillation and assumed atrial flutter at the beginning of the 
hospital admission, the patient started oral anticoagulation 
therapy and treatment with a beta blocker. Radiofrequency 
ablation was considered, although refrained from due to the 
expected unacceptably high risk related to the massively 
thickened intra-atrial septum.
At the eight months control, the patient was in good con-
dition and did not have any further episodes of palpitations. A 
new TTE showed unchanged findings without growth of the 
cardiac mass. Further clinical and TTE control is planned to 
assess whether LASH grows and whether the patient eventu-
ally develops any cardiac symptoms that may alter the decision 
of no surgery.
3 |  TIMELINE
Day 1 Admission to cardiac unit with palpitations. 
Regular supraventricular tachycardia at 
213 bpm. Transient AV block induced by 
Adenosine showed flutter waves. Conversion to 
sinus rhythm by intravenous administration of 
300 mg Amiodarone.
Day 2 Stable condition. Initiation of treatment with beta 
blocker.
Day 3-5 Transthoracic echocardiogram (TTE) shows 
a solid mass 5 × 3 cm in the right atrium. 
Transesophageal echocardiogram gives 
suspicion of myxoma. Referred to cardiac 
computed tomography (CT) to exclude coronary 
artery disease. Discharge from hospital.
Day 17 Cardiac CT shows normal coronary arteries. 
Referred to cardiac surgery.
Day 24 Heart team conference: Doubt about the 
diagnosis myxoma. Referred to cardiac 
magnetic resonance (CMR) prior to surgery.
Day 45 CMR with T1- and T2-weighted images 
including fat suppression revealed widespread 
lipomatous atrial septum hypertrophy due to 
fatty infiltration.
Day 57 Conference with electrophysiologist: decision 
on avoiding radiofrequency ablation and 
continuing medical treatment for SVT. Initiation 
of anticoagulation.
Day 207
(8 mo after 
admission 
date)
Stable condition. No episodes of palpitations. 
New TTE: unchanged findings without growth 
of the cardiac mass. Follow-up clinical and TTE 
control is planned.
4 |  DISCUSSION
4.1 | Lipomatous atrial septal hypertrophy
LASH is thickening and hyperplasia of the intra-atrial 
septum and is defined by non-encapsulated hyperplasia of 
normal fat in the septum with a diameter >2 cm.4 LASH is 
associated with older age, female sex, coronary artery dis-
ease, and obesity.5-7 It was first described at a postmortem 
examination in 1964.6 Typically, LASH is an incidental 
finding on autopsy.8 Currently, the condition is detected 
more often in living patients because of more frequent 
use of noninvasive imaging. LASH is usually asympto-
matic and requires no treatment. If obstructive symptoms 
are present, for example, congestive heart failure due to 
obstruction of the superior vena cava, surgical removal 
might be preferred. Previous studies have described an as-
sociation between LASH and SVT due to the localization 
close to the conduction system connecting sinoatrial and 
atrioventricular nodes.6
It is important to distinguish LASH from lipomas since 
the choice of treatment is generally different. Lipomas and 
LASH are related by the tissue composition and arise from 
benign neoplastic proliferation of mature adipocytes.9-11 In 
contrast to LASH, lipomas are usually enclosed in a capsule 
and grow neoplastic.12 Lipomas can have both epicardial 
and endocardial localizations.3,13-15 Endocardial lipomas are 
broad-based, without a narrow stalk, and tend to grow into 
the neighboring chamber. If lipomas are epicardially located, 
they are presented with a narrow stalk and grow into the peri-
cardial space.
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An important question in our case arises, how certain is 
the diagnosis of LASH based on noninvasive imaging only. 
It is generally accepted that LASH can be safely diagnosed 
by noninvasive imaging methods if the typical feature with 
a “dumbbell” configuration with sparing of the central fossa 
ovalis and a fatty component is identified by CMR.12 The 
second question is whether the SVT was associated with 
LASH. The risk factors associated with LASH are also those 
associated with atrial fibrillation, for example, agingand 
obesity. More studies are needed to clarify whether there is 
an independent association between LASH and the occur-
rence of SVT. However, in an elderly patient with obesity, an 
atrial arrhythmia might be associated with LASH if no other 
causative conditions are present, for example, valvular heart 
disease or heart failure. Thus, in our patient, it is not unlikely 
that the SVT was associated with LASH.
4.2 | Cardiac imaging in evaluation of 
cardiac tumors
Approximately 75% of primary cardiac tumors are benign, 
with 50% of them being myxomas.2,16 The remainder con-
sists of papillary elastomas (20%), lipomas (15%-20%), and 
hemangiomas (5%). Around 25% of primary cardiac tumors 
are malignant, the majority of them being sarcomas (95%) 
F I G U R E  1  A-F, Thickened intra-
atrial septum consistent with lipomatous 
hypertrophy due to fatty infiltration 
(marked by asterisk). A, Transesophageal 
echocardiogram. B, Contrast-enhanced 
computed tomography (CT). C, T1-
weighted cardiovascular magnetic resonance 
(CMR). D, T1-weighted CMR with fat 
suppression. E, Still image of postcontrast 
balanced steady-state free precession CMR. 
F, Inversion-recovery gradient-echo CMR 
without late gadolinium enhancement in 
the interatrial septum. Note, the isointense 
signal from the intra-atrial septum compared 
to pericardial fat on CT and CMR
(A) (B)
(C) (D)
(E) (F)
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and less frequently lymphomas (5%). Metastases to the heart 
and pericardium (secondary cardiac tumors) are 100-1000 
times more frequent than primary tumors.10
Because of its availability, TTE is the imaging technique 
of choice, but it is heavily operator-dependent. In addition, 
the restricted field of view and the patient´s body habitus can 
affect the complete assessment of the cardiac mass. TOE per-
mits a more detailed characterization of a cardiac tumor in 
terms of size, morphology, attachment site, extension, valvu-
lar lesions, and hemodynamic effects.
Nevertheless, neither TTE nor TOE provides sufficient 
tissue characterization or distinction between benign and 
malignant tumors. While preoperative biopsy is performed 
in some cases, this intervention is accompanied by a risk 
of complications such as embolization and hematogenous 
dissemination with aggravating consequences for the pa-
tient, especially if the tumor is located on the left side of 
the heart.17
Computed tomography can provide important additional 
information not readily available with echocardiography, in 
particular, on exact anatomic localization of the tumor, de-
termination of any local invasion or extension into adjacent 
organs, and presence of coronary calcification (unlike CMR). 
Limitations of CT include the exposure to ionizing radiation, 
lower temporal resolution compared with echocardiography 
or CMR, and lower soft-tissue contrast resolution compared 
with CMR.10
Advantages of CMR when compared to echocardiogra-
phy are larger field of view, better tissue characterization 
based on typical tissue signal intensities, exact anatomic 
description of the tumor, lack of attenuation and ability to 
image at any prescribed plane.18 The main limitation of 
CMR when compared to echocardiography is lower tem-
poral resolution. Therefore, CMR is generally not suitable 
for the evaluation of valvular vegetations.12 Table 1 shows 
anatomic features and imaging characteristics of LASH, 
myxoma, and lipoma. Diagnostic evaluation of these three 
types of masses can be difficult because of their similari-
ties. However, the anatomic location together with infor-
mation on whether the mass is well defined, presence of a 
capsule, and appearance on CMR images might lead closer 
to the diagnosis.
When a cardiac mass has characteristic features of a cer-
tain cardiac tumor, CMR might not be necessary to make a 
diagnosis. When the cardiac mass causes hemodynamic com-
plications, urgent surgery might be performed and additional 
imaging modalities such as CMR might cause delay in the 
treatment. When surgery is performed, a precise histological 
diagnosis will be present afterwards. Thus, additional CMR 
might be useful in situations where the diagnosis is not clear 
after echocardiographic examinations.
In conclusion, a team-based approach might be favor-
able in the diagnostic evaluation of patients with cardiac T
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masses. Application of several imaging modalities might 
improve the diagnostic evaluation prior to decision on car-
diac surgery.
5 |  PATIENT PERSPECTIVE
We suggest that patients with cardiac masses undergo evalu-
ation in a team-based approach. We suggest that colleagues 
from other specialties such as cardiothoracic surgery, radi-
ology, and oncology are involved in an early phase in the 
diagnostic evaluation. CMR could be a supplemental exami-
nation before the final decision on surgery to clarify the ana-
tomic and functional changes. Furthermore, we suggest that 
the international cardiology societies establish a consensus 
document on assessing patients with cardiac masses.
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